Edition:
India

Pharmaceuticals

More industries within Healthcare sector:

Kissei Pharmaceutical says marketing approval for "Beova® Tablets 50mg" for treatment of overactive bladder

Sept 21(Reuters) - Kissei Pharmaceutical Co Ltd :Says Kissei Pharmaceutical Co Ltd and KYORIN Holdings, Inc. jointly announced today that KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., received approval from the Ministry of Health, Labour and Welfare as of September 21,...

12:24pm IST

Kissei Pharmaceutical says marketing approval for "Beova® Tablets 50mg" for treatment of overactive bladder

Sept 21(Reuters) - Kissei Pharmaceutical Co Ltd :Says Kissei Pharmaceutical Co Ltd and KYORIN Holdings, Inc. jointly announced today that KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., received approval from the Ministry of Health, Labour and Welfare as of September 21,...

12:24pm IST

Astellas Pharma announces approval in Japan for XOSPATA® 40 mg Tablets for treatment of FLT3mut+ relapsed or refractory AML

Sept 21(Reuters) - Astellas Pharma Inc :Says it announced that XOSPATA® Tablets 40 mg, a FLT3 (FMS-like tyrosine kinase 3) inhibitor received manufacturing and marketing approval for the treatment of FLT3 mutation-positive relapsed or refractory acute myeloid leukemia (AML) in Japan.

12:15pm IST

Sun Pharma Industries Gets Australian Regulator Approval For Psoriasis Drug

Sept 21 (Reuters) - Sun Pharmaceutical Industries Ltd ::RECEIVED AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION APPROVAL FOR SPECIALITY PRODUCT, ILUMYA.SUN PHARMACEUTICAL INDUSTRIES- DRUG FOR TREATMENT OF ADULTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS WHO ARE CANDIDATES FOR SYSTEMIC THERAPY.

11:43am IST

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

More industries within Healthcare sector: